Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cerevel Therapeutics Hldg Inc (NQ: CERE )

32.80 -0.87 (-2.58%)
Streaming Delayed Price Updated: 2:55 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 166,541
Open 33.87
Bid (Size) 32.81 (2)
Ask (Size) 32.87 (2)
Prev. Close 33.67
Today's Range 32.58 - 33.99
52wk Range 22.10 - 41.46
Shares Outstanding 8,830,700
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Expectations for Cerevel Therapeutics Hldg's Future
 
Via Benzinga
Top 5 Health Care Stocks That Should Keep You Up At Night
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga

Performance

YTD
+5.98%
+5.98%
1 Month
-0.09%
-0.09%
3 Month
+27.03%
+27.03%
6 Month
+19.80%
+19.80%
1 Year
+14.65%
+14.65%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Via Benzinga
Analyst Expectations for Cerevel Therapeutics Hldg's Future
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Via Benzinga
Cerevel Therapeutics Hldg: Q1 Earnings Insights
Via Benzinga
Where Cerevel Therapeutics Hldg Stands With Analysts
Via Benzinga
Analyst Expectations for Cerevel Therapeutics Hldg's Future
Via Benzinga
Data Shows Cerevel's Emraclidine Does Not Induce High Blood Pressure In Schizophrenia Patients
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023
Via Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
Via Benzinga
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'
Via Benzinga
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Via Benzinga
Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33%
Via Benzinga
Why Cerevel Therapeutics Holdings Shares Are Nosediving
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Via Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.